Douglas J Abeles, MD
Orthopedic Surgery · Castro Valley
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- 10
- 2 carriers
- Offices
- 2
On the public record
- 1 Medical Board action on record
- Owns East Bay Special Surgery, LLC: Accreditation Lapsed
Offices
2 locations · Douglas J Abeles MD Inc · Health Diagnostics of California A Professional Corporation
Hospitals listed: Eden Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abeles’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G79953 · Current
Licensed to practise in California · since 1994 · expires 2028-07-31 · George Washington University School of Medicine. Board flags: Probation Completed.
Public record actions
| 2025-07-22 | Board disciplineDiscipline | Probation completed. · 8002018042374 |
Surgery centers they own
- East Bay Special Surgery, LLCAmbulatory Surgery Center · Oakland, CA7% owner since 2009 · accredited by AAAHCAccreditation Lapsed2 inspections, 1 with deficiencies · last 2013-06-21: Requirements Met
- Redwood Surgery Center, LPAmbulatory Surgery Center · Castro Valley, CA50% owner since 2010 · accredited by AAAHCAccreditation Renewed5 inspections, 2 with deficiencies · last 2023-06-20: Requirements Met
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$95,922
Medicare paid this office $95,922 for 139 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 108 | $40,292 | $108 |
| Short return visit (20+ min) | 72 | $18,871 | $82 |
| Aspiration and/or injection of fluid from large joint | 40 | $8,797 | $59 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 19 | $7,112 | None |
| New patient visit (45+ min) | 35 | $4,649 | $133 |
See all 6 services
| Return visit (30+ min) | 108 | $40,292 | $108 |
| Short return visit (20+ min) | 72 | $18,871 | $82 |
| Aspiration and/or injection of fluid from large joint | 40 | $8,797 | $59 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 19 | $7,112 | None |
| New patient visit (45+ min) | 35 | $4,649 | $133 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | $68 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Who their Medicare patients are
139 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 9% · Women 64% · Also on Medicaid 35% · Health risk score 1.30. Above the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Depression 41% · Diabetes 36% · Chronic kidney disease 22% · Coronary heart disease 19% · COPD 19% · Heart failure 17% · Atrial fibrillation 17% · Cancer 12%.
The office billed $1,029,521, Medicare allowed $125,308 and paid $95,922; for 1,243 services of 38 kinds; $7,896 of it was for drugs given in the office and $88,025 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 139 | 1,243 | 73 | 1.30 | $1,029,521 | $95,922 |
| 2023 | 137 | 1,272 | 72 | 1.36 | $662,170 | $90,975 |
| 2022 | 161 | 3,546 | 71 | 1.05 | $682,609 | $136,805 |
| 2021 | 150 | 2,891 | 69 | 1.23 | $905,334 | $165,185 |
| 2020 | 153 | 1,942 | 70 | 1.31 | $745,974 | $123,528 |
| 2019 | 198 | 1,982 | 72 | 1.57 | $883,543 | $164,977 |
| 2018 | 169 | 1,855 | 69 | 1.26 | $755,905 | $134,500 |
| 2017 | 160 | 1,786 | 68 | 1.38 | $581,457 | $117,984 |
| 2016 | 173 | 1,837 | 67 | 1.17 | $569,740 | $126,877 |
| 2015 | 163 | 1,501 | 67 | 1.32 | $224,982 | $94,178 |
| 2014 | 301 | 1,659 | 71 | 1.35 | $353,139 | $138,543 |
| 2013 | 417 | 3,052 | 72 | 1.50 | $596,833 | $268,527 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 99 | $36,289 | $105 |
| Short return visit (20+ min) | 103 | $21,641 | $77 |
| Aspiration and/or injection of fluid from large joint | 26 | $4,899 | $58 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 12 | $2,474 | None |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 14 | $1,952 | $103 |
| New patient visit (30+ min) | 20 | $1,838 | $92 |
| New patient visit (45+ min) | 11 | $1,615 | $147 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $1,419 | $43 |
| Short return visit | 11 | $879 | $46 |
| X-ray of lower and sacral spine, minimum of 4 views | 11 | $182 | $11 |
| X-ray of pelvis, 1-2 views | 11 | $122 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $61 | None |
2022: 13 services
| Short return visit (20+ min) | 128 | $43,268 | $70 |
| Return visit (30+ min) | 89 | $26,414 | $113 |
| Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 13 | $24,628 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 57 | $15,787 | $85 |
| New patient visit (30+ min) | 36 | $2,821 | $78 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 15 | $2,250 | $98 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 15 | $1,773 | $43 |
| Aspiration and/or injection of fluid from large joint | 14 | $1,275 | $58 |
| Short return visit | 11 | $613 | $44 |
| Telephone, internet, or electronic health record assessment and management with verbal and written report by consulting physician, 5-10 minutes | 26 | $558 | $15 |
| X-ray of lower and sacral spine, minimum of 4 views | 18 | $303 | $11 |
| X-ray of pelvis, 1-2 views | 19 | $218 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $113 | None |
2021: 17 services
| Short return visit (20+ min) | 126 | $47,457 | $77 |
| Return visit (30+ min) | 105 | $41,350 | $109 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 67 | $18,537 | $89 |
| X-ray of lower and sacral spine, minimum of 4 views | 52 | $3,141 | $48 |
| New patient visit (30+ min) | 28 | $2,443 | $87 |
| X-ray of knee, 4 or more views | 41 | $2,220 | $42 |
| New patient visit (45+ min) | 13 | $1,787 | $137 |
| X-ray of upper spine, 4-5 views | 27 | $1,352 | $50 |
| X-ray of shoulder, minimum of 2 views | 33 | $1,310 | $34 |
| X-ray of middle spine, 2 views | 32 | $1,299 | $30 |
| Short return visit | 20 | $1,290 | $52 |
| X-ray of hip, 2-3 views | 21 | $1,060 | $39 |
| X-ray of knee, 3 views | 19 | $918 | $40 |
| X-ray of hip, 1 view | 11 | $315 | $29 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $199 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 70 | $162 | None |
| X-ray of pelvis, 1-2 views | 13 | $134 | $7 |
2020: 19 services
| Return visit (30+ min) | 121 | $42,170 | $91 |
| Short return visit (20+ min) | 99 | $20,100 | $64 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 53 | $11,906 | $87 |
| X-ray of lower and sacral spine, minimum of 4 views | 53 | $2,804 | $45 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $2,511 | None |
| New patient visit (45+ min) | 19 | $2,290 | $121 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 12 | $1,729 | $102 |
| X-ray of knee, 4 or more views | 31 | $1,405 | $39 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | $1,312 | $45 |
| New patient visit (30+ min) | 16 | $1,272 | $80 |
| X-ray of middle spine, 2 views | 31 | $1,063 | $30 |
| X-ray of shoulder, minimum of 2 views | 29 | $1,054 | $32 |
| X-ray of knee, 3 views | 28 | $1,000 | $36 |
| X-ray of upper spine, 4-5 views | 19 | $887 | $47 |
| X-ray of hip, 2-3 views | 15 | $752 | $44 |
| Telephone or internet assessment with verbal and written report by consulting physician, 11-20 minutes | 14 | $468 | $31 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $273 | $11 |
| X-ray of pelvis, 1-2 views | 16 | $176 | $8 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 55 | $119 | None |
2019: 15 services
| Return visit (30+ min) | 151 | $77,165 | $91 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 68 | $20,779 | $86 |
| Short return visit (20+ min) | 101 | $14,171 | $64 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 16 | $7,720 | None |
| New patient visit (45+ min) | 38 | $5,153 | $136 |
| X-ray of lower and sacral spine, minimum of 4 views | 31 | $1,452 | $45 |
| New patient visit (30+ min) | 16 | $1,310 | $82 |
| X-ray of knee, 3 views | 25 | $927 | $34 |
| X-ray of hip, 2-3 views | 18 | $767 | $40 |
| X-ray of shoulder, minimum of 2 views | 18 | $656 | $29 |
| X-ray of upper spine, 4-5 views | 13 | $620 | $48 |
| X-ray of knee, 4 or more views | 12 | $515 | $40 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $228 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 57 | $146 | None |
| X-ray of pelvis, 1-2 views | 12 | $113 | $8 |
2018: 17 services
| Return visit (30+ min) | 127 | $49,970 | $88 |
| Short return visit (20+ min) | 109 | $17,165 | $53 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 66 | $14,360 | $85 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $5,618 | None |
| New patient visit (45+ min) | 37 | $4,522 | $122 |
| Radiological supervision and interpretation x-ray of covering of spinal cord | 15 | $2,171 | $103 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 18 | $1,751 | $42 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 16 | $1,749 | $97 |
| New patient visit (30+ min) | 16 | $1,344 | $84 |
| X-ray of lower and sacral spine, minimum of 4 views | 19 | $858 | $43 |
| X-ray of hip, 2-3 views | 15 | $660 | $35 |
| X-ray of knee, 4 or more views | 12 | $441 | $34 |
| X-ray of shoulder, minimum of 2 views | 15 | $404 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $402 | $31 |
| X-ray of lower and sacral spine, minimum of 4 views | 19 | $328 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $186 | None |
| X-ray of pelvis, 1-2 views | 19 | $184 | $7 |
2017: 16 services
| Short return visit (20+ min) | 128 | $32,387 | $57 |
| Return visit (30+ min) | 95 | $18,927 | $78 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 60 | $14,445 | $82 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $6,134 | None |
| New patient visit (30+ min) | 42 | $3,271 | $78 |
| X-ray of lower and sacral spine, minimum of 4 views | 34 | $1,233 | $34 |
| X-ray of knee, 4 or more views | 29 | $1,002 | $30 |
| Imaging guidance for procedure, 60 minutes or less | 11 | $789 | $39 |
| Short return visit | 18 | $721 | $36 |
| X-ray of shoulder, minimum of 2 views | 17 | $579 | $21 |
| X-ray of hip, 2-3 views | 13 | $567 | $31 |
| X-ray of upper spine, 4-5 views | 14 | $481 | $34 |
| X-ray of ankle, minimum of 3 views | 11 | $466 | $23 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $246 | $12 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $212 | None |
| X-ray of pelvis, 1-2 views | 16 | $110 | $6 |
2016: 18 services
| Return visit (30+ min) | 111 | $34,406 | $85 |
| Short return visit (20+ min) | 123 | $23,181 | $57 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 61 | $13,950 | $72 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 22 | $6,080 | None |
| New patient visit (45+ min) | 25 | $3,239 | $130 |
| New patient visit (30+ min) | 27 | $2,139 | $79 |
| X-ray of lower and sacral spine, minimum of 4 views | 34 | $1,512 | $41 |
| X-ray of knee, 4 or more views | 26 | $1,087 | $34 |
| Short return visit | 26 | $940 | $28 |
| X-ray of shoulder, minimum of 2 views | 27 | $769 | $25 |
| Imaging guidance for procedure, 60 minutes or less | 12 | $711 | $40 |
| X-ray of hip, 2-3 views | 18 | $682 | $36 |
| X-ray of upper spine, 4-5 views | 14 | $577 | $38 |
| X-ray of knee, 3 views | 11 | $402 | $31 |
| X-ray of lower and sacral spine, minimum of 4 views | 19 | $363 | $13 |
| X-ray of middle spine, 2 views | 12 | $350 | $29 |
| X-ray of pelvis, 1-2 views | 20 | $217 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 67 | $184 | None |
2015: 18 services
| Short return visit (20+ min) | 123 | $28,082 | $59 |
| Return visit (30+ min) | 78 | $16,230 | $88 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 39 | $9,811 | $77 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 14 | $4,706 | None |
| New patient visit (45+ min) | 23 | $3,105 | $135 |
| New patient visit (30+ min) | 34 | $2,778 | $82 |
| Short return visit | 31 | $1,518 | $36 |
| X-ray of lower and sacral spine, minimum of 4 views | 28 | $1,444 | $42 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,437 | $50 |
| X-ray of knee, 4 or more views | 20 | $688 | $33 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $593 | $40 |
| Injection into tendon or ligament | 11 | $591 | $42 |
| X-ray of knee, 1-2 views | 12 | $419 | $25 |
| X-ray of shoulder, minimum of 2 views | 11 | $343 | $26 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $283 | $13 |
| X-ray of shoulder, 1 view | 13 | $268 | $21 |
| X-ray of pelvis, 1-2 views | 15 | $152 | $7 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 63 | $139 | None |
2014: 17 services
| Return visit (30+ min) | 197 | $42,186 | $86 |
| Short return visit (20+ min) | 102 | $15,502 | $60 |
| New patient visit (45+ min) | 93 | $12,529 | $135 |
| Aspiration and/or injection of fluid from large joint | 42 | $4,405 | $42 |
| Ultrasonic guidance for needle placement | 34 | $4,023 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,303 | $165 |
| Mri scan of leg joint without contrast | 18 | $1,733 | $72 |
| Mri scan of arm joint without contrast | 18 | $1,562 | $74 |
| Aspiration and/or injection of fluid from medium joint | 23 | $1,091 | $40 |
| Injection into tendon or ligament | 18 | $1,021 | $43 |
| X-ray of lower and sacral spine, minimum of 4 views | 19 | $852 | $45 |
| X-ray of wrist, minimum of 3 views | 15 | $849 | $34 |
| X-ray of shoulder, minimum of 2 views | 23 | $704 | $28 |
| Short return visit | 14 | $564 | $38 |
| X-ray of ribs of one side of body, minimum of 2 views | 15 | $551 | $34 |
| X-ray of hand, minimum of 3 views | 11 | $363 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 78 | $162 | None |
2013: 25 services
| Return visit (30+ min) | 294 | $83,870 | $90 |
| Short return visit (20+ min) | 93 | $33,579 | $61 |
| New patient visit (45+ min) | 163 | $22,334 | $137 |
| Ultrasonic guidance for needle placement | 61 | $18,608 | $181 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $10,131 | $161 |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 11 | $10,071 | $916 |
| Aspiration and/or injection of fluid from large joint | 66 | $8,471 | $47 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 16 | $5,869 | None |
| Release and/or relocation of hand nerve | 15 | $3,794 | $253 |
| Aspiration and/or injection of fluid from medium joint | 40 | $2,559 | $52 |
| Injection, cidofovir, 375 mg | 60 | $2,247 | None |
| X-ray of wrist, minimum of 3 views | 35 | $1,995 | $36 |
| Injection into tendon or ligament | 29 | $1,901 | $48 |
| X-ray of shoulder, minimum of 2 views | 45 | $1,704 | $28 |
| Mri scan of leg joint without contrast | 27 | $1,676 | $54 |
| Mri scan of arm joint without contrast | 22 | $1,402 | $52 |
| X-ray of finger, minimum of 2 views | 26 | $1,114 | $32 |
| Muscle electrical test | 12 | $987 | $76 |
| X-ray of lower and sacral spine, minimum of 4 views | 22 | $985 | $45 |
| X-ray of ribs of one side of body, minimum of 2 views | 20 | $985 | $36 |
| Application of elbow to finger cast | 12 | $882 | $74 |
| X-ray of knee, 3 views | 17 | $666 | $35 |
| X-ray of hand, minimum of 3 views | 12 | $642 | $31 |
| X-ray of ankle, minimum of 3 views | 11 | $595 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 114 | $229 | None |
Drugs they prescribed that Part D paid
$21,784
Pharmacies billed $21,784 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 10% of their Part D prescriptions (88 of 916) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
913 generic and fewer than 11 brand-name prescriptions · $21,784 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 335 | $6,831 | $20 |
| Diclofenac | 171 | $6,421 | $38 |
| Lidocaine | 25 | $5,184 | $207 |
| Hydrocodone-Acetaminophen | 72 | $1,065 | $15 |
| Gabapentin | 107 | $857 | $8 |
See all 11 drugs
| Celecoxib | 335 | $6,831 | $20 |
| Diclofenac | 171 | $6,421 | $38 |
| Lidocaine | 25 | $5,184 | $207 |
| Hydrocodone-Acetaminophen | 72 | $1,065 | $15 |
| Gabapentin | 107 | $857 | $8 |
| Pregabalin | 13 | $503 | $39 |
| Naproxen | 21 | $215 | $10 |
| Ibuprofen | 33 | $211 | $6 |
| Cyclobenzaprine | 31 | $105 | $3 |
| Meloxicam | 49 | $97 | $2 |
| Prednisone | 17 | $57 | $3 |
Year by year
| 2024 | 916 | 231 | 10% (88) | None | $21,784 |
| 2023 | 1,246 | 168 | 37% (465) | None | $30,119 |
| 2022 | 1,590 | 180 | 49% (780) | None | $47,578 |
| 2021 | 1,206 | 140 | 59% (708) | 2% | $41,460 |
| 2020 | 811 | 127 | 67% (546) | 2% | $30,456 |
| 2019 | 859 | 113 | 69% (591) | 4% | $34,934 |
| 2018 | 1,050 | 110 | 62% (654) | 3% | $38,846 |
| 2017 | 811 | 109 | 61% (492) | 4% | $37,386 |
| 2016 | 795 | 120 | 60% (477) | 5% | $38,018 |
| 2015 | 869 | 112 | 52% (449) | 3% | $39,730 |
| 2014 | 467 | 100 | 54% (252) | 9% | $27,551 |
| 2013 | 450 | 85 | 59% (265) | 10% | $23,363 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Hydrocodone-Acetaminophen | 388 | $8,790 | $23 |
| Lidocaine | 28 | $4,275 | $153 |
| Celecoxib | 136 | $2,722 | $20 |
| Diclofenac | 96 | $2,048 | $21 |
| Pregabalin | 50 | $1,927 | $39 |
| Gabapentin | 84 | $1,322 | $16 |
| Tizanidine | 11 | $1,321 | $120 |
| Cyclobenzaprine | 74 | $800 | $11 |
| Meloxicam | 124 | $671 | $5 |
| Naproxen | 56 | $577 | $10 |
| Ibuprofen | 40 | $540 | $14 |
| Omeprazole | 22 | $525 | $24 |
| Oxycodone | 20 | $483 | $24 |
| Oxycodone-Acetaminophen | 13 | $319 | $25 |
| Tramadol | 41 | $231 | $6 |
| Prednisone | 11 | $58 | $5 |
| Alprazolam | 14 | $12 | $1 |
2022: 19 drugs
| Hydrocodone-Acetaminophen | 603 | $15,842 | $26 |
| Oxycontin | 13 | $15,274 | $1,175 |
| Gabapentin | 122 | $1,912 | $16 |
| Oxycodone | 43 | $1,853 | $43 |
| Oxycodone-Acetaminophen | 76 | $1,737 | $23 |
| Celecoxib | 68 | $1,625 | $24 |
| Pregabalin | 33 | $1,463 | $44 |
| Ibuprofen | 72 | $886 | $12 |
| Diclofenac | 64 | $874 | $14 |
| Meloxicam | 136 | $660 | $5 |
| Cyclobenzaprine | 83 | $630 | $8 |
| Omeprazole | 27 | $375 | $14 |
| Naproxen | 49 | $326 | $7 |
| Tramadol | 38 | $239 | $6 |
| Diazepam | 27 | $156 | $6 |
| Prednisone | 25 | $125 | $5 |
| Carisoprodol | 11 | $64 | $6 |
| Trazodone | 12 | $29 | $2 |
| Hydroxyzine Pamoate | 12 | $23 | $2 |
2021: 17 drugs
| Hydrocodone-Acetaminophen | 545 | $14,800 | $27 |
| Oxycontin | 13 | $14,224 | $1,094 |
| Oxycodone-Acetaminophen | 78 | $2,035 | $26 |
| Oxycodone | 40 | $1,908 | $48 |
| Celecoxib | 59 | $1,461 | $25 |
| Gabapentin | 87 | $1,392 | $16 |
| Pregabalin | 13 | $801 | $62 |
| Ibuprofen | 45 | $538 | $12 |
| Diclofenac | 30 | $399 | $13 |
| Fentanyl | 12 | $363 | $30 |
| Cyclobenzaprine | 52 | $292 | $6 |
| Meloxicam | 58 | $272 | $5 |
| Prednisone | 40 | $218 | $5 |
| Diazepam | 23 | $152 | $7 |
| Omeprazole | 13 | $145 | $11 |
| Naproxen | 20 | $110 | $5 |
| Carisoprodol | 12 | $48 | $4 |
2020: 15 drugs
| Oxycontin | 11 | $11,203 | $1,018 |
| Hydrocodone-Acetaminophen | 426 | $10,259 | $24 |
| Oxycodone-Acetaminophen | 47 | $2,187 | $47 |
| Oxycodone | 35 | $1,513 | $43 |
| Gabapentin | 42 | $651 | $15 |
| Celecoxib | 24 | $626 | $26 |
| Fentanyl | 11 | $502 | $46 |
| Diclofenac | 12 | $417 | $35 |
| Ibuprofen | 25 | $328 | $13 |
| Meloxicam | 42 | $171 | $4 |
| Prednisone | 28 | $149 | $5 |
| Cyclobenzaprine | 20 | $120 | $6 |
| Diazepam | 12 | $71 | $6 |
| Hydromorphone | 12 | $71 | $6 |
| Carisoprodol | 12 | $32 | $3 |
2019: 15 drugs
| Oxycontin | 14 | $12,243 | $874 |
| Hydrocodone-Acetaminophen | 464 | $10,690 | $23 |
| Oxycodone | 47 | $2,401 | $51 |
| Oxycodone-Acetaminophen | 45 | $2,348 | $52 |
| Narcan | 12 | $1,572 | $131 |
| Celecoxib | 35 | $954 | $27 |
| Gabapentin | 42 | $586 | $14 |
| Fentanyl | 13 | $494 | $38 |
| Ibuprofen | 23 | $292 | $13 |
| Naproxen | 17 | $230 | $14 |
| Methylprednisolone | 11 | $145 | $13 |
| Diazepam | 24 | $110 | $5 |
| Meloxicam | 24 | $109 | $5 |
| Cyclobenzaprine | 14 | $104 | $7 |
| Alprazolam | 14 | $30 | $2 |
2018: 19 drugs
| Hydrocodone-Acetaminophen | 480 | $11,659 | $24 |
| Oxycontin | 12 | $10,418 | $868 |
| Oxycodone-Acetaminophen | 79 | $2,385 | $30 |
| Oxycodone | 51 | $2,134 | $42 |
| Celecoxib | 34 | $1,808 | $53 |
| Fentanyl | 19 | $944 | $50 |
| Gabapentin | 35 | $469 | $13 |
| Temazepam | 34 | $398 | $12 |
| Ibuprofen | 22 | $281 | $13 |
| Naproxen | 33 | $281 | $9 |
| Diazepam | 48 | $232 | $5 |
| Cyclobenzaprine | 20 | $220 | $11 |
| Ibu | 12 | $149 | $12 |
| Methylprednisolone | 12 | $149 | $12 |
| Cephalexin | 24 | $145 | $6 |
| Zolpidem | 12 | $143 | $12 |
| Meloxicam | 26 | $115 | $4 |
| Topiramate | 11 | $85 | $8 |
| Alprazolam | 12 | $24 | $2 |
2017: 15 drugs
| Hydrocodone-Acetaminophen | 365 | $7,169 | $20 |
| Celecoxib | 18 | $1,922 | $107 |
| Fentanyl | 16 | $1,459 | $91 |
| Oxycodone | 35 | $1,459 | $42 |
| Oxycodone-Acetaminophen | 43 | $935 | $22 |
| Gabapentin | 30 | $454 | $15 |
| Cyclobenzaprine | 23 | $297 | $13 |
| Naproxen | 42 | $275 | $7 |
| Zolpidem | 14 | $264 | $19 |
| Ibuprofen | 26 | $240 | $9 |
| Diazepam | 35 | $234 | $7 |
| Cephalexin | 36 | $185 | $5 |
| Temazepam | 13 | $167 | $13 |
| Hydromorphone | 14 | $99 | $7 |
| Meloxicam | 18 | $86 | $5 |
2016: 17 drugs
| Hydrocodone-Acetaminophen | 342 | $11,490 | $34 |
| Oxycodone-Acetaminophen | 59 | $2,224 | $38 |
| Celecoxib | 20 | $2,044 | $102 |
| Fentanyl | 18 | $1,056 | $59 |
| Oxycodone | 21 | $1,006 | $48 |
| Voltaren | 11 | $544 | $49 |
| Gabapentin | 30 | $481 | $16 |
| Zolpidem | 20 | $410 | $21 |
| Ibuprofen | 30 | $404 | $13 |
| Naproxen | 33 | $300 | $9 |
| Methylprednisolone | 15 | $237 | $16 |
| Diazepam | 35 | $199 | $6 |
| Cephalexin | 23 | $106 | $5 |
| Prednisone | 11 | $78 | $7 |
| Hydromorphone | 13 | $74 | $6 |
| Meloxicam | 15 | $65 | $4 |
| Cyclobenzaprine | 12 | $32 | $3 |
2015: 16 drugs
| Hydrocodone-Acetaminophen | 289 | $9,007 | $31 |
| Oxycontin | 16 | $8,601 | $538 |
| Oxycodone-Acetaminophen | 77 | $6,828 | $89 |
| Oxycodone | 50 | $2,836 | $57 |
| Celecoxib | 14 | $2,158 | $154 |
| Gabapentin | 45 | $589 | $13 |
| Cyclobenzaprine | 26 | $472 | $18 |
| Ibuprofen | 28 | $310 | $11 |
| Zolpidem | 30 | $298 | $10 |
| Methylprednisolone | 15 | $294 | $20 |
| Naproxen | 35 | $277 | $8 |
| Omeprazole | 21 | $236 | $11 |
| Diazepam | 42 | $217 | $5 |
| Cephalexin | 24 | $150 | $6 |
| Carisoprodol | 19 | $128 | $7 |
| Meloxicam | 40 | $127 | $3 |
2014: 10 drugs
| Hydrocodone-Acetaminophen | 167 | $5,318 | $32 |
| Celebrex | 14 | $4,123 | $294 |
| Lidocaine | 16 | $3,639 | $227 |
| Oxycodone | 36 | $3,338 | $93 |
| Oxycodone-Acetaminophen | 29 | $3,029 | $104 |
| Carisoprodol | 22 | $365 | $17 |
| Omeprazole | 14 | $219 | $16 |
| Ibuprofen | 17 | $181 | $11 |
| Diazepam | 29 | $177 | $6 |
| Naproxen | 19 | $163 | $9 |
2013: 10 drugs
| Lidoderm | 20 | $5,153 | $258 |
| Hydrocodone-Acetaminophen | 179 | $4,386 | $25 |
| Celebrex | 16 | $3,050 | $191 |
| Oxycodone Hcl-Acetaminophen | 36 | $2,571 | $71 |
| Oxycodone | 35 | $2,092 | $60 |
| Carisoprodol | 27 | $309 | $11 |
| Omeprazole | 12 | $205 | $17 |
| Zolpidem | 29 | $200 | $7 |
| Ibuprofen | 11 | $79 | $7 |
| Cephalexin | 11 | $57 | $5 |
Money from drug and device companies
$304 in 2025
| 2025 | 5 | 11 | None | $304 |
| 2024 | 2 | 3 | None | $54 |
| 2023 | 6 | 6 | None | $222 |
| 2022 | 7 | 17 | None | $584 |
| 2021 | 7 | 25 | None | $424 |
| 2020 | 4 | 16 | None | $439 |
| 2019 | 10 | 15 | None | $490 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Eterna | $138 | 7 payments
|
| Providence Medical Technology | None | $93 | 1 payment
|
| Globus Medical | Senza | $33 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $26 | 1 payment
|
| Orthofix Medical | Physio-Stim | $14 | 1 payment
|
See all 11 published payments
| Globus Medical | Meals · 2025-12-08 | Senza | $33 |
| Abbott Laboratories | Meals · 2025-11-27 | Eterna | $29 |
| Abbott Laboratories | Meals · 2025-11-27 | Eterna | $30 |
| Abbott Laboratories | Meals · 2025-11-27 | Eterna | $11 |
| Abbott Laboratories | Meals · 2025-11-27 | Proclaim | $6 |
| Orthofix Medical | Meals · 2025-10-13 | Physio-Stim | $14 |
| Abbott Laboratories | Meals · 2025-09-24 | Eterna | $16 |
| Abbott Laboratories | Meals · 2025-08-11 | Eterna | $24 |
| Abbott Laboratories | Meals · 2025-07-15 | Eterna | $22 |
| ConvaTec | Meals · 2025-07-10 | Aquacel Ag+ Extra | $26 |
| Providence Medical Technology | Meals · 2025-05-09 | None | $93 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $54
| Abbott Laboratories | Proclaim | $40 | 2 payments
|
| DePuy Synthes Sales | Orthovisc | $14 | 1 payment
|
2023: $222
| Wenzel Spine | Vma | $124 | 1 payment
|
| Nevro | Senza | $28 | 1 payment
|
| Collegium Pharmaceutical | Belbuca | $20 | 1 payment
|
| Smith+Nephew | Pico | $20 | 1 payment
|
| Bioventus | Durolane | $16 | 1 payment
|
| Abbott Laboratories | Proclaim | $13 | 1 payment
|
2022: $584
| Abbott Laboratories | Proclaim | $216 | 5 payments
|
| Teva Pharmaceuticals USA | Ajovy | $123 | 1 payment
|
| Wenzel Spine | Vma | $109 | 1 payment
|
| Si-Bone | None | $60 | 2 payments
|
| Forte Bio-Pharma | Prolate | $39 | 1 payment
|
| Trevena | Olinvyk | $22 | 1 payment
|
| Orthofix Medical | Physio-Stim | $14 | 1 payment
|
2021: $424
| Abbott Laboratories | Proclaim Ipg | $325 | 18 payments
|
| DePuy Synthes Sales | Monovisc | $29 | 1 payment
|
| Pacira Pharmaceuticals | Iovera System | $18 | 1 payment
|
| Forte Bio-Pharma | Nalocet | $18 | 1 payment
|
| Bioventus | Supartz Fx Sodium Hyaluronate | $11 | 1 payment
|
| Horizon Therapeutics plc | Pennsaid | $11 | 1 payment
|
| Orthofix Medical | Physio-Stim | $11 | 1 payment
|
2020: $439
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $277 | 13 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $123 | 1 payment
|
| Bioventus | Motys | $23 | 1 payment
|
| Ermi | None | $17 | 1 payment
|
2019: $490
| Abbott Laboratories | Proclaim Family of Scs Ipgs | $161 | 2 payments
|
| Orexo US | Zubsolv | $114 | 1 payment
|
| BioDelivery Sciences International | Bunavail 2.1 Mg 30-Count Box | $53 | 3 payments
|
| Electronic Waveform Lab | None | $45 | 2 payments
|
| Kaleo | Evzio | $34 | 2 payments
|
| Bioventus | Exogen | $21 | 1 payment
|
| Flexion Therapeutics | Zilretta | $18 | 1 payment
|
| Vertiflex | Superion Iss | $18 | 1 payment
|
| Axogen | Axoguard Nerve Protector | $13 | 1 payment
|
| ConvaTec | Aquacel | $11 | 1 payment
|
Professional record
- NPI
- 1508961582
- Licence
- CA G79953California G79953: Current · expires 2028-07-31
- Trained
- George Washington University School of Medicine, 1987
- Group
- Douglas J Abeles MD Inc · Health Diagnostics of California A Professional Corporation
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Orthopedic surgery (207X00000X)
- Mailing address
- 21030 Redwood Rd, Castro Valley, CA, 94546
- NPI first listed
- 2006-09-14
- NPI last updated
- 2013-06-10
This is when the NPI record was last certified, not a medical board exam.